Objective:

To advance care and community engagement for Huntington's disease under the leadership of Nicolas Phielipp, MD.

Approach:

• Leadership: Nicolas Phielipp, MD, leads the center, enhancing its role since it became a Huntington’s Disease Society of America-designated center in 2019.
• Multidisciplinary Care: The program delivers multidisciplinary care that includes genetic counseling, specialty neurologic care, and integrated support from rehabilitation therapists and social workers for both patients and families.
• New Initiatives: The Rare Neurological Diseases Multidisciplinary Clinic, led by Ravi Rajmohan, MD, PhD, streamlines care by enabling patients to see multiple specialists in a single coordinated visit.
• Community Collaboration: Expanded collaboration with community partners has strengthened access to resources and support services.
• Research Efforts: Ongoing research efforts include participation in the global Enroll-HD study and a $12 million CIRM-funded stem cell clinical trial led by Leslie Thompson, PhD.

Key Findings:

• The center has been designated by the Huntington’s Disease Society of America since 2019.
• Multidisciplinary care includes genetic counseling and support from various specialists.
• The new clinic allows for coordinated specialist visits.
• Collaboration with community partners enhances resource access.
• Ongoing research positions UCI at the forefront of Huntington’s disease innovation.

Interpretation:

The UCI Health Huntington’s Disease Center is enhancing its services and research capabilities under new leadership.

Conclusion:

The center's advancements in care and research are significant for the Huntington's disease community.